Candida tropicalis

Summary

Alias:

Top Publications

  1. doi Biodegradation of international jet A-1 aviation fuel by microorganisms isolated from aircraft tank and joint hydrant storage systems
    A Y Itah
    University of Uyo, Uyo, Nigeria
    Bull Environ Contam Toxicol 83:318-27. 2009
  2. doi In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp
    Patricia Pozzatti
    Department of Microbiology and Parasitology, Mycology Division, Universidade Federal de Santa Maria, Santa Maria, RS 97105 900, Brazil
    Can J Microbiol 54:950-6. 2008
  3. ncbi Antimicrobial activity of some macrophytes from Lake Manzalah (Egypt)
    M F Fareed
    Department of Home Economic, Faculty of Specific Education, Tanta University, Tanta, Egypt
    Pak J Biol Sci 11:2454-63. 2008
  4. doi Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species
    H M H N Bandara
    Oral Biosciences, Faculty of Dentistry, University of Hong Kong, 5 F Prince Philip Dental Hospital, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR
    J Med Microbiol 59:1225-34. 2010
  5. pmc Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms
    Sophie Joly
    Dows Institute for Dental Research, University of Iowa, Iowa City, Iowa 52242, USA
    J Clin Microbiol 42:1024-9. 2004
  6. pmc International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
    M A Pfaller
    Department of Pathology, Iowa City, Iowa 52242, USA
    J Clin Microbiol 39:3254-9. 2001
  7. ncbi [Evaluation of a new method for antifungal drugs susceptibility testing to yeasts]
    S Ishigaki
    Department of Central Laboratory, Teikyo School of Medicine
    Kansenshogaku Zasshi 74:221-30. 2000
  8. pmc Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003
    Po Ren Hsueh
    Department of Laboratory Medicine, National Taiwan University Hospital, No 7 Chung Shan South Rd, Taipei 100, Taiwan
    Antimicrob Agents Chemother 49:512-7. 2005
  9. ncbi In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts
    Guillermo Quindos
    Departamento de Inmunologia, Microbiologia y Parasitologia, Facultad de Medicina y Odontologia, Universidad del Pais Vasco, Bilbao, Spain
    Rev Iberoam Micol 21:63-9. 2004
  10. ncbi In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens
    M S Ellabib
    Department of Medical Microbiology, Faculty of Medicine, Al Fateh University, PO Box 13497, Tripoli, Libya
    Saudi Med J 22:860-3. 2001

Research Grants

  1. Allison M Porman; Fiscal Year: 2014
  2. FIBRONECTIN RECEPTOR IN CANDIDA TROPICALIS
    MARGARET HOSTETTER; Fiscal Year: 2003
  3. TARGETING PROTEINS TO CANDIDA TROPICALIS PEROXISOMES
    PAUL LAZAROW; Fiscal Year: 1990
  4. FUNCTION OF B-DEFENSINS IN COMMON ORAL INFECTIONS
    Janet Guthmiller; Fiscal Year: 2002
  5. Lethal synergism between influenza and pneumococcus
    Jonathan McCullers; Fiscal Year: 2003
  6. 2nd Orthomyxoviruses Research Conference
    Jonathan McCullers; Fiscal Year: 2003
  7. Influenza-pneumococcal synergism: role of neuraminidase
    Jonathan McCullers; Fiscal Year: 2004
  8. High through-put detection of fungal pathogens
    JACK FELL; Fiscal Year: 2004
  9. Prevention/diagnosis/fungal infections/transplantation
    Barbara Alexander; Fiscal Year: 2005
  10. 3rd Orthomyxoviruses Research Conference
    Jonathan McCullers; Fiscal Year: 2005

Patents

  1. BIOLOGICAL METHODS FOR PREPARING A FATTY DICARBOXYLIC ACID
  2. BIOLOGICAL METHODS FOR PREPARING A FATTY DICARBOXYLIC ACID
  3. NMR SYSTEMS AND METHODS FOR THE RAPID DETECTION OF ANALYTES
  4. NMR SYSTEMS AND METHODS FOR THE DETECTION OF ANALYTES
  5. Method for Simultaneous detection of pathogenic fungi
  6. Enzymatic omega-oxidation and omega-amination of fatty acid
  7. Method of identifying eukaryotic species
  8. Xylitol production method with high productivity using constitutive expression of xylose reductase
  9. A hydrocarbon synthesis gene and use thereof
  10. PROCESS AND METHOD FOR MONITORING GASTROINTESTINAL MICROBIOTA

Detail Information

Publications195 found, 100 shown here

  1. doi Biodegradation of international jet A-1 aviation fuel by microorganisms isolated from aircraft tank and joint hydrant storage systems
    A Y Itah
    University of Uyo, Uyo, Nigeria
    Bull Environ Contam Toxicol 83:318-27. 2009
    ..Others included Candida tropicalis, Candida albicans, Saccharomyces estuari, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Aspergillus ..
  2. doi In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp
    Patricia Pozzatti
    Department of Microbiology and Parasitology, Mycology Division, Universidade Federal de Santa Maria, Santa Maria, RS 97105 900, Brazil
    Can J Microbiol 54:950-6. 2008
    ..The Candida species studied were Candida albicans, Candida dubliniensis, Candida tropicalis, Candida glabrata, and Candida krusei. For comparison purposes, they were arranged in groups as C...
  3. ncbi Antimicrobial activity of some macrophytes from Lake Manzalah (Egypt)
    M F Fareed
    Department of Home Economic, Faculty of Specific Education, Tanta University, Tanta, Egypt
    Pak J Biol Sci 11:2454-63. 2008
    ..subtilis 1020, Bacillus cereus 1080, Staphylococcus aureus, Erwinia carotovora NCPPB 312, Candida albicans, Candida tropicalis, Aspergillus niger, Fusarium oxysporum and Penicillium italicum...
  4. doi Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species
    H M H N Bandara
    Oral Biosciences, Faculty of Dentistry, University of Hong Kong, 5 F Prince Philip Dental Hospital, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR
    J Med Microbiol 59:1225-34. 2010
    ..of Candida, comprising Candida albicans ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258, Candida tropicalis ATCC 13803, Candida parapsilosis ATCC 22019 and Candida dubliniensis MYA 646, was studied using a standard ..
  5. pmc Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms
    Sophie Joly
    Dows Institute for Dental Research, University of Iowa, Iowa City, Iowa 52242, USA
    J Clin Microbiol 42:1024-9. 2004
    ..micros, Actinomyces naeslundii, Actinomyces israelii, Streptococcus sanguis, Streptococcus mutans, Candida tropicalis, Candida parapsilosis, Candida krusei, Candida glabrata, and Candida albicans)...
  6. pmc International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
    M A Pfaller
    Department of Pathology, Iowa City, Iowa 52242, USA
    J Clin Microbiol 39:3254-9. 2001
    ..of the yeast BSIs were due to Candida albicans, followed by Candida glabrata and Candida parapsilosis (15%), Candida tropicalis (9%), and miscellaneous Candida spp. (6%). In the United States, 45% of candidemias were due to non-C...
  7. ncbi [Evaluation of a new method for antifungal drugs susceptibility testing to yeasts]
    S Ishigaki
    Department of Central Laboratory, Teikyo School of Medicine
    Kansenshogaku Zasshi 74:221-30. 2000
    ..isolates of yeasts (7 Candida albicans, 8 Candida glabrata, 10 Candida parapsilosis, 6 Pichia anomala, 10 Candida tropicalis, 4 Candida guilliermondii, 4 Candida krusei, 6 Trichosporon cutaneum, 5 Candida ciferrii, 3 Candida famata, ..
  8. pmc Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003
    Po Ren Hsueh
    Department of Laboratory Medicine, National Taiwan University Hospital, No 7 Chung Shan South Rd, Taipei 100, Taiwan
    Antimicrob Agents Chemother 49:512-7. 2005
    ..krusei, 11% (23 of 207 isolates) for Candida albicans, 3.0% (2 of 67 isolates) for Candida tropicalis, 20% (12 of 59 isolates) for C. glabrata, and 0% for both Candida parapsilosis and Candida lusitaniae...
  9. ncbi In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts
    Guillermo Quindos
    Departamento de Inmunologia, Microbiologia y Parasitologia, Facultad de Medicina y Odontologia, Universidad del Pais Vasco, Bilbao, Spain
    Rev Iberoam Micol 21:63-9. 2004
    ..140 Candida parapsilosis, 68 Candida glabrata, 41 Candida dubliniensis, 50 Candida guilliermondii, 34 Candida tropicalis, 28 Candida krusei, 20 Candida famata, 11 Cryptococcus neoformans, 5 Cryptococcus albidus, 43 Rhodotorula ..
  10. ncbi In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens
    M S Ellabib
    Department of Medical Microbiology, Faculty of Medicine, Al Fateh University, PO Box 13497, Tripoli, Libya
    Saudi Med J 22:860-3. 2001
    ..To study the susceptibility pattern of candida species isolated from various clinical specimens to common usable antifungals in Libya...
  11. ncbi In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period
    Emine Kucukates
    Laboratory of Microbiology and Clinical Microbiology, Institute of Cardiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    APMIS 113:278-83. 2005
    ..The most commonly isolated yeast was Candida albicans (72.6%), followed by Candida tropicalis (16.2%), Candida kefyr, Candida krusei, Candida parapsilosis, Trichosporon mucoides and Geotrichum spp...
  12. pmc Multidrug resistant yeasts in synanthropic wild birds
    Alexander Tiong Kah Lord
    The International Medical University, Kuala Lumpur, Malaysia
    Ann Clin Microbiol Antimicrob 9:11. 2010
    ..The aim of this study was to investigate the presence of multidrug resistant yeasts in the faeces of synanthropic wild birds from the Bangsar suburb of Kuala Lumpur...
  13. ncbi [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents]
    Fatma Kaynak Onurdağ
    Gazi Üniversitesi Eczacılık Fakültesi, Farmasötik Mikrobiyoloji Anabilim Dalı, Ankara, Turkiye
    Mikrobiyol Bul 44:619-31. 2010
    ..albicans, C.parapsilosis and Candida tropicalis. Microdilution method was used to determine the susceptibilities of planktonic forms of the strains ..
  14. pmc DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients
    Birgit Spiess
    III Medizinische Universitätsklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Theodor Kutzer Ufer 1 3, D 68167, Mannheim, Germany
    J Clin Microbiol 45:3743-53. 2007
    ..flavus, Aspergillus terreus, Candida albicans, Candida dubliniensis, Candida glabrata, Candida lusitaniae, Candida tropicalis, Fusarium oxysporum, Fusarium solani, Mucor racemosus, Rhizopus microsporus, Scedosporium prolificans, and ..
  15. ncbi Candida yeast long chain fatty alcohol oxidase is a c-type haemoprotein and plays an important role in long chain fatty acid metabolism
    Qi Cheng
    Department of Biological and Biomedical Sciences, University of Durham, South Road, Durham DH1 3LE, UK
    Biochim Biophys Acta 1735:192-203. 2005
    The industrial yeasts Candida tropicalis or Candida cloacae are able to grow on a variety of long chain alkanes and fatty acids as the sole carbon source...
  16. ncbi Candidemia and the susceptibility pattern of Candida isolates in blood
    Abimbola O Osoba
    Division of Microbiology, King Khalid National Guard Hospital, Jeddah, Kingdom of Saudi Arabia
    Saudi Med J 24:1060-3. 2003
    ..The purpose of our study was to determine the prevalence of Candida species among our bloodstream infecting organisms and the susceptibility pattern of the Candida isolates to antifungal agents...
  17. ncbi In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole
    A J Carrillo-Munoz
    Department of Microbiology, Asesoría Científica y de Investigación Aplicada, Barcelona, Spain
    J Antimicrob Chemother 44:397-401. 1999
    ..strains of Candida albicans, Candida parapsilosis, Candida glabrata, Candida krusei, Candida guilliermondii, Candida tropicalis, Candida kefyr, Candida viswanathii, Candida famata, Candida rugosa, Rhodotorula rubra, Trichosporon spp...
  18. ncbi [Background and prognostic factors of fungemia in patients with hematological disease]
    H Ujiie
    Fifth Department of Internal Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases
    Kansenshogaku Zasshi 72:912-7. 1998
    ..Trichosporon beigelii and Candida tropicalis were the most frequently isolated fungal pathogens. The prevalence of C. crusei increased while that of C...
  19. pmc DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses
    Daniele Campa
    Dipartimento di Biologia, Sezione di Genetica, Universita di Pisa, Pisa, Italy
    J Clin Microbiol 46:909-15. 2008
    ..genera, including Candida species (Candida albicans, Candida dubliniensis, Candida famata, Candida glabrata, Candida tropicalis, Candida kefyr, Candida krusei, Candida guilliermondii, Candida lusitaniae, Candida metapsilosis, Candida ..
  20. ncbi Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options
    Eugene Leibovitz
    Pediatric Infections Disease Unit, Soroka University Medical Center, PO Box 151, Beer Sheva 84101, Israel
    J Antimicrob Chemother 49:69-73. 2002
    ..encountered fungal infections are caused by Candida albicans, Candida parapsilosis and, rarely, by Candida tropicalis. Amphotericin B (with or without flucytosine) is the treatment of choice for Candida infections in neonates...
  21. doi Molecular identification of yeast species associated with 'Hamei'--a traditional starter used for rice wine production in Manipur, India
    K Jeyaram
    Microbial Resources Division, Institute of Bioresources and Sustainable Development IBSD, Takyelpat Institutional Area, Imphal, Manipur, India
    Int J Food Microbiol 124:115-25. 2008
    ..Nine groups were identified as S. cerevisiae, Pichia anomala, Trichosporon sp., Candida tropicalis, Pichia guilliermondi, Candida parapsilosis, Torulaspora delbrueckii, Pichia fabianii and Candida montana by ..
  22. doi Candida species extracellular alcohols: production and effect in sessile cells
    Margarida Martins
    Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, Universidade do Minho, Campus de Gualtar, Braga, Portugal
    J Basic Microbiol 50:S89-97. 2010
    ..Herein, Candida parapsilosis and Candida tropicalis extracellular alcohols production by planktonic cultures was analyzed by headspace-solid-phase ..
  23. ncbi [Mycological analysis of clinical materials of patients receiving total parenteral nutrition]
    Maria Dabkowska
    Katedra i Zakład Mikrobiologii Lekarskiej, Warszawski Uniwersytet Medyczny
    Med Dosw Mikrobiol 62:163-70. 2010
    ..4%), 13 strains of Candida albicans (23.6%), 3 Candida tropicalis strains, 2 Candida krusei strains, 2 Candida lusitaniae strains and 1 strain of Candida inconspicua were ..
  24. ncbi [Investigation of antifungal activity of Ononis spinosa L. ash used for the therapy of skin infections as folk remedies]
    Ergin Murat Altuner
    Kastamonu Üniversitesi Fen Edebiyat Fakültesi, Biyoloji Bolumu, Kastamonu, Turkiye
    Mikrobiyol Bul 44:633-9. 2010
    ..albicans, Candida glabrata, Candida tropicalis, Candida krusei, Candida guilliermondii, Candida parapsilosis, Candida pelliculosa, Trichosporon asahii, ..
  25. doi Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation
    H M H N Bandara
    Faculty of Dentistry, University of Hong Kong, Oral Biosciences, 5 F Prince Phillip Dental Hospital, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR
    J Med Microbiol 58:1623-31. 2009
    ..species of Candida, Candida albicans ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258, Candida tropicalis ATCC 13803, Candida parapsilosis ATCC 22019 and Candida dubliniensis MYA-646, were studied using a standard ..
  26. ncbi The epidemiology of candidaemia and mould infections in Australia
    Monica A Slavin
    Department of Infectious Diseases, The Royal Melbourne Hospital, Gratton Street, Parkville, VIC 3050, Melbourne, Australia
    J Antimicrob Chemother 49:3-6. 2002
    ..5% Candida tropicalis. There were significant differences in the distribution of species in different patient groups...
  27. pmc Streptococcus thermophilus and its biosurfactants inhibit adhesion by Candida spp. on silicone rubber
    H J Busscher
    Laboratory for Materia Technica, University of Groningen, The Netherlands
    Appl Environ Microbiol 63:3810-7. 1997
    The adhesion of yeasts, two Candida albicans and two Candida tropicalis strains isolated from naturally colonized voice prostheses, to silicone rubber with and without a salivary conditioning film in the absence and presence of adhering ..
  28. pmc Lysine biosynthesis in selected pathogenic fungi: characterization of lysine auxotrophs and the cloned LYS1 gene of Candida albicans
    R C Garrad
    Department of Microbiology, Miami University, Oxford, Ohio 45056
    J Bacteriol 174:7379-84. 1992
    ..Seven lysine auxotrophs of C. albicans and one of Candida tropicalis were characterized biochemically to determine the biochemical blocks and gene-enzyme relationships...
  29. ncbi Risk factors for disseminated candidiasis in children with candidemia
    Theoklis E Zaoutis
    Division of Infectious Diseases, The Children s Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Pediatr Infect Dis J 23:635-41. 2004
    ..To determine the risk factors for disseminated infection in hospitalized children with candidemia...
  30. ncbi Fungal endophthalmitis: fourteen years' experience from a center in India
    Arunaloke Chakrabarti
    Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
    Retina 28:1400-7. 2008
    ....
  31. doi Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever
    Michael Ellis
    Department of Medicine, Faculty of Medicine and Health Sciences, UAE University, and Department of Oncology, Tawam Hopkins Hospital, Al Ain, UAE
    J Med Microbiol 58:606-15. 2009
    ..These included candidaemia due to Candida albicans (one patient) or Candida tropicalis (four patients), and hepatosplenic candidiasis (seven patients)...
  32. ncbi Prospective evaluation of the new chromogenic medium CandiSelect 4 for differentiation and presumptive identification of the major pathogenic Candida species
    Boualem Sendid
    Laboratoire de Mycologie Fondamentale and Appliquée Inserm, U799 CHRU, Avenue J Leclercq, 59045 Lille Cedex, France
    J Med Microbiol 56:495-9. 2007
    ..albicans, 60 Candida glabrata, 25 Candida tropicalis, 12 Candida krusei and 53 other Candida species. The percentage of C...
  33. pmc In vitro activity of a new oral triazole, BMS-207147 (ER-30346)
    J C Fung-Tomc
    Bristol Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA
    Antimicrob Agents Chemother 42:313-8. 1998
    ..itraconazole and fluconazole were inactive against strains of Candida krusei and Candida tropicalis. In contrast, all but 9 (all C...
  34. pmc Identification and characterization of the CYP52 family of Candida tropicalis ATCC 20336, important for the conversion of fatty acids and alkanes to alpha,omega-dicarboxylic acids
    David L Craft
    Biotechnology Group, Cognis Corporation, Cincinnati, Ohio 45232, USA
    Appl Environ Microbiol 69:5983-91. 2003
    b>Candida tropicalis ATCC 20336 excretes alpha,omega-dicarboxylic acids as a by-product when cultured on n-alkanes or fatty acids as the carbon source...
  35. ncbi In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest
    Ralf Fleck
    Institute of Medical Microbiology and Hygiene, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Germany
    J Antimicrob Chemother 59:767-71. 2007
    ..Since quick results of in vitro testing are desirable, Etest and the CLSI broth microdilution (BMD) method (reference method) were compared, focusing on the validity of early readings...
  36. doi Effect of phenotypic switching on expression of virulence factors by Candida albicans causing candidiasis in diabetic patients
    Georgy Antony
    Department of Microbiology, Kasturba Medical College, Manipal University, Mangalore 575001, India
    Rev Iberoam Micol 26:202-5. 2009
    ..They were Candida albicans 53 (47%), Candida tropicalis 36 (33%), Candida glabrata 9 (8%), Candida parapsilosis 4 (4%), Candida guilliermondii 2 (2%), Candida ..
  37. doi Silicone colonization by non-Candida albicans Candida species in the presence of urine
    Sonia Silva
    Institute for Biotechnology and Bioengineering, Universidade do Minho, Campus de Gualtar, 4710 057 Braga, Portugal
    J Med Microbiol 59:747-54. 2010
    ..g. Candida glabrata, Candida tropicalis and Candida parapsilosis) has been recognized...
  38. ncbi Prevalence of yeasts in beach sand at three bathing beaches in South Florida
    C Vogel
    SUNY, Marine Sciences Research Center, Stony Brook, NY 11794 5000, USA
    Water Res 41:1915-20. 2007
    ..The most frequently encountered yeasts were Candida tropicalis and Rhodotorula mucilaginosa...
  39. ncbi A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study
    C Jessup
    Center for Medical Mycology, Case Western Reserve University, Cleveland, OH, USA
    J Chemother 12:22-9. 2000
    ..parapsilosis (n=23), Candida krusei (n=19), Candida lusitaniae (n=14), Cryptococcus neoformans (n=5), Candida tropicalis (n=12), Aspergillus flavus (n=34), Aspergillus fumigatus (n=46) and 68 other filamentous fungi encompassing ..
  40. ncbi Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment
    M Belazi
    Department of Oral Medicine and Maxillofacial Pathology, School of, Dentistry, Aristotle University of Thessaloniki, Greece
    Oral Microbiol Immunol 19:347-51. 2004
    ..the infection was Candida albicans (n = 23), followed by Candida glabrata (n = 3), Candida krusei (n = 2), Candida tropicalis (n = 1) and Candida kefyr (n = 1)...
  41. ncbi Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR
    Mark G Wise
    Bacterial Barcodes Inc, Athens, GA 30602, USA
    J Med Microbiol 56:778-87. 2007
    ..Initially, 41 clinical Candida spp. (7 Candida krusei, 10 Candida parapsilosis, 7 Candida albicans, 10 Candida tropicalis and 7 Candida glabrata), previously identified at the species level by morphological and biochemical ..
  42. ncbi Antifungal activity of some Tanzanian plants used traditionally for the treatment of fungal infections
    Omar J M Hamza
    Department of Oral Surgery and Oral Pathology, Muhimbili University College of Health Sciences, P O Box 65014, Dar es Salaam, Tanzania
    J Ethnopharmacol 108:124-32. 2006
    ..skin were collected and screened for their antifungal activity against Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei and Cryptococcus neoformans...
  43. pmc Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp
    M Cuenca-Estrella
    Servicio de Micologia, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain
    J Clin Microbiol 39:525-32. 2001
    ..clinical isolates (Candida albicans, Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei, and Candida lusitaniae [10 isolates each]) are ..
  44. pmc Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group
    P Sandven
    Department of Bacteriology, National Institute of Public Health, 0462 Oslo, Norway
    J Clin Microbiol 36:3455-9. 1998
    ..5%), Candida parapsilosis (7.6%), and Candida tropicalis (6.4%). The incidences of both C. albicans (range, 63 to 73%) and C. glabrata (range, 8.4 to 15...
  45. ncbi Identification of fungemia agents using the polymerase chain reaction and restriction fragment length polymorphism analysis
    M S Santos
    Laboratorio de Micologia, Gerência de Bacteriologia, Fundacao de Medicina Tropical do Amazonas, Manaus, AM, Brasil
    Braz J Med Biol Res 43:712-6. 2010
    ..of the present study was to identify the following fungemia agents: Candida albicans, Candida parapsilosis, Candida tropicalis, Candida glabrata, Cryptococcus neoformans, Cryptococcus gattii, and Histoplasma capsulatum using the ..
  46. ncbi In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus
    A J Carrilo-Muñoz
    Unitat de Micologia, Institut Municipal D investigacio IMIM, Universitat Autonoma de Barcelona, Spain
    J Antimicrob Chemother 37:815-9. 1996
    ..Candida glabrata, 2 Candida guilliermodii, 8 Candida krusei, 1 Candida kefyr, 8 Candida parapsilosis and 26 Candida tropicalis) was assessed in comparison with bifonazole, ketoconazole, econazole and miconazole...
  47. doi Microbial diversity of traditional Vietnamese alcohol fermentation starters (banh men) as determined by PCR-mediated DGGE
    Vu Nguyen Thanh
    Department of Microbiology, Food Industries Research Institute, 301 Nguyen Trai, Thanh Xuan, Hanoi, Vietnam
    Int J Food Microbiol 128:268-73. 2008
    ..Pichia anomala, Candida tropicalis, P...
  48. ncbi Development of a xylitol biosensor composed of xylitol dehydrogenase and diaphorase
    K Takamizawa
    Department of Bioprocessing, Faculty of Agriculture, Gifu University, Japan
    Can J Microbiol 46:350-7. 2000
    In preparation for the development of a xylitol biosensor, the xylitol dehydrogenase of Candida tropicalis IFO 0618 was partially purified and characterized. The optimal pH and temperature of the xylitol dehydrogenase were pH 8...
  49. pmc Potent in vitro antifungal activities of naturally occurring acetylenic acids
    Xing Cong Li
    National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, MS 38677, USA
    Antimicrob Agents Chemother 52:2442-8. 2008
    ..for their in vitro antifungal activities against Candida albicans, Candida glabrata, Candida krusei, Candida tropicalis, Candida parapsilosis, Cryptococcus neoformans, Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger,..
  50. ncbi A regulatory factor, Fil1p, involved in derepression of the isocitrate lyase gene in Saccharomyces cerevisiae--a possible mitochondrial protein necessary for protein synthesis in mitochondria
    T Kanai
    Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Japan
    Eur J Biochem 256:212-20. 1998
    A mutant was isolated that failed to derepress the 5' upstream region of Candida tropicalis isocitrate lyase gene (UPR-ICL)-mediated gene expression in acetate medium, and the gene (FIL1) that complemented this mutation was isolated...
  51. doi Antifungal activity of essential oils of Croton species from the Brazilian Caatinga biome
    R O S Fontenelle
    Faculty of Veterinary, Postgraduate Program in Veterinary Sciences, State University of Ceara, Fortaleza, Ceara, Brazil
    J Appl Microbiol 104:1383-90. 2008
    ..To find new antifungal agents among essential oils from Brazilian Croton species...
  52. ncbi Molecular cloning, sequencing and sequence analysis of the fox-2 gene of Neurospora crassa encoding the multifunctional beta-oxidation protein
    A Fossa
    Institut fur Physiologische Chemie, Abteilung für Zellbiochemie, Ruhr Universitat Bochum, Germany
    Mol Gen Genet 247:95-104. 1995
    ..protein comprises 894 amino acid residues and exhibits 45% and 47% sequence identity with the MFPs of Candida tropicalis and Saccharomyces cerevisiae, respectively...
  53. pmc Cloning and characterization of the xyl1 gene, encoding an NADH-preferring xylose reductase from Candida parapsilosis, and its functional expression in Candida tropicalis
    Jung Kul Lee
    BioNgene Co, Ltd, Jongro Ku, Seoul 110 521, Korea
    Appl Environ Microbiol 69:6179-88. 2003
    ..b>Candida tropicalis KFCC-10960 has been reported to have the highest xylitol production yield and rate...
  54. pmc Decreased accumulation or increased isoleucyl-tRNA synthetase activity confers resistance to the cyclic beta-amino acid BAY 10-8888 in Candida albicans and Candida tropicalis
    K Ziegelbauer
    Bayer AG, Institut für Antiinfektiva Forschung, Wuppertal, Germany
    Antimicrob Agents Chemother 42:1581-6. 1998
    ..Furthermore, we have characterized BAY 10-8888 transport and isoleucyl-tRNA synthetase activity in several Candida tropicalis strains which showed MICs higher than those of other Candida strains. An analysis of the C...
  55. ncbi Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles
    Eva R Trösken
    Department of Toxicology, University of Wurzburg, Versbacher Str 9, Wurzburg, Germany
    Toxicology 228:24-32. 2006
    ..CYP51 of Candida albicans (cCYP51) was co-expressed with Candida tropicalis oxidoreductase in the baculovirus system. IC(50) values of 13 fungicides for cCYP51 ranged about six-fold (0...
  56. ncbi Antimicrobial effect, in vitro, of gutta-percha points containing root canal medications against yeasts and Enterococcus faecalis
    Meltem Dartar Oztan
    Faculty of Dentistry, Department of Endodontics, Ankara University, Ankara, Turkey
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:410-6. 2006
    ..The objective of this study was to determine the in vitro susceptibility of Enterococcus faecalis and the most prevalent Candida species as therapy-resistant microorganisms to gutta-percha points containing root canal medications...
  57. ncbi Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals
    Marcio Nucci
    University Hospital, Hematology Service, Mycology Laboratory, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
    Diagn Microbiol Infect Dis 58:77-82. 2007
    b>Candida tropicalis is the 2nd most frequent agent of candidemia in Brazil (20-24%). We attempted to characterize the epidemiology, microbiology, and outcome of candidemia due to C. tropicalis by comparing patients with candidemia due to C...
  58. ncbi Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
    P Munoz
    Department of Clinical Microbiology and Infectious Diseases, Hospital General Gregorio Maranon, Ibiza 46, 28007, Madrid, Spain
    Int J Antimicrob Agents 15:83-90. 2000
    ..They should also be considered in patients with a colonisation index >0.5 or a corrected colonization index >0.4 or when the isolate is identified as Candida tropicalis.
  59. ncbi Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals
    Theoklis E Zaoutis
    Division of Infectious Diseases, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Diagn Microbiol Infect Dis 52:295-8. 2005
    ..isolates were the second most frequently identified (57/175, 32%), followed by Candida glabrata, Candida tropicalis, and Candida lusitaniae (approximately 8% each)...
  60. doi Synthesis and the selective antifungal activity of 5,6,7,8-tetrahydroimidazo[1,2-a]pyridine derivatives
    Ahmet Ozdemir
    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey
    Eur J Med Chem 45:2080-4. 2010
    ..a panel of ten human pathogenic Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis, Candida utilis, and Candida zeylanoides using agar diffusion and broth microdilution assays, respectively...
  61. doi A sensitive and a rapid multiplex polymerase chain reaction for the identification of Candida species in concentrated oral rinse specimens in patients with diabetes
    Asanga Sampath
    A Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
    Acta Odontol Scand 75:113-122. 2017
    ..is associated with multiple pathogens including Candida albicans, Candida parapsilosis, Candida glabrata and Candida tropicalis. The aim of this study was to evaluate a usefulness of a Multiplex Polymerase Chain Reaction as a rapid ..
  62. pmc Production of freeze-dried yeast culture for the brewing of traditional sorghum beer, tchapalo
    Florent K N'guessan
    Laboratoire de Biotechnologie et Microbiologie des Aliments Unité de Formation et de Recherche en Sciences et Technologie des Aliments UFR STA Université Nangui Abrogoua 02 BP 801 Abidjan 02 Côte d Ivoire
    Food Sci Nutr 4:34-41. 2016
    ..The yeast strains Saccharomyces cerevisiae F 12-7 and Candida tropicalis C 0-7 previously isolated from sorghum beer were used in a mixed culture at a ratio of 2:1 (C. tropicalis/S...
  63. ncbi Isolation and characterization of phenol-degrading yeasts from an oil refinery wastewater in Brazil
    Lidianne Leal Rocha
    Laboratory of Microbiology and Immunology, Department of Biology, Sciences Center, Federal University of Ceara, Campus do Pici, Bloco 909, Fortaleza, CE, CEP, Brazil
    Mycopathologia 164:183-8. 2007
    ..These species were identified through morphological and biochemical characteristics as Candida tropicalis, C. rugosa, and Pichia membranaefaciens...
  64. doi Antifungal cyclic peptides from Psammosilene tunicoides
    Junmian Tian
    Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, People s Republic of China
    J Nat Prod 73:1987-92. 2010
    ..showed a broad spectrum of antifungal activity against Candida albicans (SC5314), Candida albicans (Y0109), Candida tropicalis, Candida parapsilosis, and Cryptococcus neoformans (BLS108) with MIC(80) values of 4.0, 16.0, 0.25, 1...
  65. doi Utilization of size polymorphism in ITS1 and ITS2 regions for identification of pathogenic yeast species
    Hossein Khodadadi
    1Shiraz University of Medical Sciences
    J Med Microbiol . 2017
    ..we were able to differentiate nearly all pathogenic yeast species, including Candida albicans, Candida tropicalis, Candida glabrata, Candida parapsilosis, Candida krusei, Candida guilliermondii, Candida kefyr, Candida ..
  66. ncbi Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole
    Hsiao Hui Chou
    Mycotic Diseases Laboratory, Center of Research and Diagnostics, Centers for Disease Control, Taipei 11561, Taiwan
    Diagn Microbiol Infect Dis 58:427-33. 2007
    Multilocus sequence typing (MLST) was used to characterize the genetic profiles of 52 Candida tropicalis isolates collected from 10 hospitals in Taiwan...
  67. doi Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study
    A F Schmalreck
    Mikrobiologische Beratung and Service, Munchen, Germany Division of Clinical Microbiology, Department of Laboratory Medicine, University Vienna, Austria
    Mycoses 55:e124-37. 2012
    ..54%) was the predominant species isolated followed by Candida glabrata (22%), Candida parapsilosis (6%), Candida tropicalis (5.7%), Candida krusei (4.3%), as well as eleven further candidal and four non-Candida yeast species...
  68. ncbi Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin
    J P Y Sim
    Department of Medicine, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong
    Hong Kong Med J 11:120-3. 2005
    Candida arthritis in patients with a haematological malignancy is rare. We report a case of Candida tropicalis arthritis of the knee that occurred in a patient with acute lymphoblastic leukaemia during the recovery phase of post-..
  69. ncbi Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds
    Hasan Küçükbay
    Department of Chemistry, Faculty of Arts and Sciences, Inonu University, 44069 Malatya, Turkey
    Farmaco 58:431-7. 2003
    ..Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and the yeasts Candida albicans and Candida tropicalis. Eleven of the compounds inhibited the growth of gram-positive bacteria (E. faecalis and S...
  70. ncbi Antimicrobial and antioxidant activities of Stachys lavandulifolia subsp. lavandulifolia essential oil and its infusion
    Gokalp Iscan
    Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey
    Nat Prod Commun 7:1241-4. 2012
    ..The oil exhibited good inhibitory activity on Candida tropicalis (MIC 0.094 mg/mL)...
  71. doi Antifungal activity and chemical composition of essential oils from Smyrnium olusatrum L. (Apiaceae) from Italy and Portugal
    B Marongiu
    Dipartimento di Scienze Chimiche, Universita degli Studi di Cagliari, Cittadella Universitaria di Monserrato, 09042 Cagliari, Italy
    Nat Prod Res 26:993-1003. 2012
    ..lethal concentration were used to evaluate the antifungal activity of the oils against Candida albicans, Candida tropicalis, Candida krusei, Candida guillermondii, Candida parapsilosis, Cryptococcus neoformans, Trichophyton rubrum, ..
  72. ncbi Effects and mechanisms of H(2)O(2) on production of dicarboxylic acid
    P Jiao
    Institute of Biochemical Engineering, Department of Chemical Engineering, Tsinghua University, Beijing, P R China, 100084
    Biotechnol Bioeng 75:456-62. 2001
    The system of producing long chain dicarboxylic acid (DCA) by Candida tropicalis is an aerobic and viscous fermentation system...
  73. ncbi Flucytosine primary resistance in Candida species and Cryptococcus neoformans
    M Cuenca-Estrella
    Servicio de Micologia, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda Madrid, Spain
    Eur J Clin Microbiol Infect Dis 20:276-9. 2001
    ..5% of Candida albicans, 5.1% of Candida tropicalis and 0.8% of Candida parapsilosis strains...
  74. doi Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation
    Gaoqi Xu
    Basic Medical College, Tianjin Medical University, 22 Qixiangtai Road, Heping District, Tianjin 300070, China
    Int J Antimicrob Agents 47:439-45. 2016
    ..C. albicans, C. parapsilosis, Candida tropicalis, Candida glabrata, Candida krusei and C. orthopsilosis) and five Aspergillus spp...
  75. doi Anti-Candida activity of Mentha arvensis and Turnera ulmifolia
    Karla K A Santos
    Laboratories of Microbiology and Molecular Biology, Regional University of Cariri, Crato, Ceara, Brazil
    J Med Food 15:322-4. 2012
    Candidiasis is the most frequent infection by opportunistic fungi, frequently caused by Candida albicans, Candida tropicalis, Candida parapsilosis, Candida glabrata, and Candida krusei. Mentha arvensis L...
  76. doi Molecular phylogenetic analysis of Candida tropicalis isolates by multi-locus sequence typing
    Mette D Jacobsen
    Aberdeen Fungal Group, Institute of Medical Sciences, Aberdeen AB25 2ZD, UK
    Fungal Genet Biol 45:1040-2. 2008
    Multi-locus sequencing data for 242 different isolates of Candida tropicalis generated a dendrogram showing 235 strains assigned to a single large recently evolved group which contained several small clonal clusters...
  77. pmc Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV
    J Adamski
    Max Planck Institut fur Experimentelle Endokrinologie, Hannover, Germany
    Biochem J 311:437-43. 1995
    ..dehydrogenase family; amino acids 343-607 which are similar to the C-terminal domains of a trifunctional Candida tropicalis enzyme and the FOX2 gene product of Saccharomyces cerevisiae; amino acids 596-736 which are similar to human ..
  78. doi A repressor activator protein1 homologue from an oleaginous strain of Candida tropicalis increases storage lipid production in Saccharomyces cerevisiae
    Atrayee Chattopadhyay
    Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India
    FEMS Yeast Res 15:fov013. 2015
    ..the identification and isolation of a putative transcription factor CtRap1 gene from an oleaginous strain of Candida tropicalis, and establishes the direct effect of its expression on the storage lipid accumulation in S...
  79. doi Anti-Candida and anti-Cryptococcus antifungal produced by marine microorganisms
    B El Amraoui
    Laboratoire de contrôle qualité en bio industrie et molécules bioactives, Faculte des Sciences, Université Chouaib Doukkali, BP 20, 24000 El Jadida, Morocco Faculté polidisciplinaire, Université Ibn Zohr, BP 271, 83000 Taroudant, Morocco Electronic address
    J Mycol Med 24:e149-53. 2014
    ..65 activity, 13 isolates have anti-Cryptococcus neoformans activity and only 6 isolates are actives against Candida tropicalis R2 resistant to nystatin and amphotericin B. Nine isolates showed strong fungicidal activity...
  80. doi A review of Candida species causing blood stream infection
    S Giri
    Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai, India
    Indian J Med Microbiol 30:270-8. 2012
    ..to Candida species are attributed to five species-Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis and Candida krusei...
  81. ncbi FR227244, a novel antifungal antibiotic from Myrothecium cinctum No. 002. II. Biological properties and mode of action
    Motoo Kobayashi
    Fermentation Research Laboratories, Fujisawa Pharmaceutical Co, Ltd, 5 2 3 Tokodai, Tsukuba, Ibaraki 300 2698, Japan
    J Antibiot (Tokyo) 57:788-96. 2004
    ..Candida utilis and Candida parapsilosis but shows low activity against Candida albicans, Candida krusei and Candida tropicalis. Specifically, FR227244 exhibits in vitro and in vivo antifungal activity against Aspergillus fumigatus...
  82. ncbi Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality
    M Weinberger
    Internal Medicine C and Infectious Diseases, Rabin Medical Centre, Beilinson Campus, Petach Tikva, Israel
    J Hosp Infect 61:146-54. 2005
    ..b>Candida tropicalis (16%) was associated with youth, severe neutropenia, acute leukaemia or bone marrow transplantation, Candida ..
  83. ncbi Comprehensive study on the occurrence and distribution of pathogenic microorganisms carried by synanthropic flies caught at different rural locations in Germany
    Maike Förster
    Institute of Zoomorphology, Cell Biology and Parasitology, Heinrich Heine University, D 40225 Dusseldorf, Germany
    J Med Entomol 46:1164-6. 2009
    ..Campylobacter jejuni and Escherichia coli-strains (EHEC, EPEC, and ETEC) and the fungi Candida albicans and Candida tropicalis. The germs could be detected in the intestines as well as on the exoskeletons of the flies...
  84. doi [Textiles with antifungal and antibacterial properties]
    U C Hipler
    Friedrich Schiller Universitat Jena, Klinik für Dermatologie und Dermatologische Allergologie
    Mycoses 51:39-43. 2008
    ..and antibacterial effect of SeaCell active in an in vitro test system against Candida albicans (DSM 11225), Candida tropicalis (ATCC 1169) and Candida krusei (ATCC 6258)...
  85. doi Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis
    Marçal Mariné
    Unitat de Microbiologia, Facultat de Medicina, IISPV, Universitat Rovira i Virgili, Carrer Sant Llorenc 21, 43201, Reus, Spain
    Int J Antimicrob Agents 34:566-9. 2009
    ..the efficacy of this new formulation for treating murine disseminated infections by Candida glabrata or Candida tropicalis. M-AMB showed a similar efficacy to that of amphotericin B deoxycholate and liposomal amphotericin B in the ..
  86. doi Candida albicans abrogates the expression of interferon-gamma-inducible protein-10 in human keratinocytes
    Yumi Shiraki
    Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan
    FEMS Immunol Med Microbiol 54:122-8. 2008
    ..albicans infection. Candida tropicalis also impaired IFN-gamma-induced IP-10 expression, but Candida glabrata did not. Heat-killed C...
  87. doi Biological decolorization of industrial dyes by Candida tropicalis and Bacillus firmus
    Sucharita Arora
    Department of Applied Chemical Sciences and Technology, Guru Nanak Dev University, Amritsar 143 005, India
    Water Sci Technol 63:761-8. 2011
    ..Ltd.) of disperse dyes were tested with Candida tropicalis and Bacillus firmus isolated respectively from contaminated soil samples and sludge of a domestic sewage ..
  88. ncbi Synthesis and characterization of (Z)-N-(1-[2-{3-[(dimethylamino)methyl)]-2-methoxyphenyl}-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl]ethylidene) benzenamine derivatives as potent antifungal agents
    Manav Malhotra
    Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ferozepur Road, Moga 142 001, India
    Acta Pol Pharm 69:433-8. 2012
    ..4f and 4h showed significant activity and 4c exhibited moderate activity against Candida albicans, Candida tropicalis and Aspergillus niger as compared with the standard antifungal agent - clotrimazole...
  89. doi Antifungal susceptibility profiles of Candida isolates from a prospective survey of invasive fungal infections in Italian intensive care units
    Anna Maria Tortorano
    Dipartimento di Sanità Pubblica Microbiologia Virologia, Universita degli Studi di Milano, Via Pascal 36, 20133 Milano, Italy
    J Med Microbiol 61:389-93. 2012
    ..6, 6.0 and 7.1 %, respectively. Candida tropicalis and Candida parapsilosis accounted for more than half of all the fluconazole resistant isolates...
  90. ncbi Antimycobacterial and antifungal isosters of salicylamides
    Karel Waisser
    Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic
    Arch Pharm (Weinheim) 336:322-35. 2003
    ..against Mycobacterium tuberculosis, Mycobacterium kansasii and Mycobacterium avium, Candida albicans, Candida tropicalis, Candida krusei, Candida glabrata, Trichosporon beigelii, Aspergillus fumigatus, Absidia corymbifera, ..
  91. doi Evaluation of antimicrobial, cytotoxic, and hemolytic activities from venom of the spider Lasiodora sp
    Felipe Roberto Borba Ferreira
    Departamento de Bioquimica, Centro de Biociencias, Universidade Federal de Pernambuco, Recife, PE, Brazil
    Toxicon 122:119-126. 2016
    ..Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus and fungistatic effect against Candida tropicalis and Candida krusei...
  92. ncbi Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients
    G Quindos
    Comité para la Estandarización de los Antifúngicos Asociación Española de Micología and Departamento de Inmunología, Microbiologia y Parasitologia, Facultad de Medicina, Universidad del Pais Vasco, Spain
    Rev Iberoam Micol 16:97-100. 1999
    ..Ketoconazole resistance was observed in 40% of C. glabrata, and 17% of Candida tropicalis. Resistance to antifungal drugs is very low in Spain and it is related to non-C. albicans isolates.
  93. doi Cloning, expression and purification of squalene synthase from Candida tropicalis in Pichia pastoris
    Pey Yee Lee
    Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
    Protein Expr Purif 94:15-21. 2014
    ..as one of the immunogenic proteins that could be a potential diagnostic candidate for the pathogenic fungus Candida tropicalis. In this study, SS from C...
  94. doi Kinetics of phenol biodegradation at high concentration by a metabolically versatile isolated yeast Candida tropicalis PHB5
    Bikram Basak
    Department of Biotechnology, National Institute of Technology Durgapur, Mahatma Gandhi Avenue, Durgapur, 713209, India
    Environ Sci Pollut Res Int 21:1444-54. 2014
    ..yeast strain PHB5 was isolated from wastewater effluent of a coke oven plant and identified as Candida tropicalis based on phylogenetic analysis. Biodegradation experiments with C...
  95. ncbi Identification of local clinical Candida isolates using CHROMagar Candida™ as a primary identification method for various Candida species
    P Madhavan
    Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Selangor, Malaysia
    Trop Biomed 28:269-74. 2011
    ..The sensitivity of this agar to identify Candida albicans, Candida dubliniensis, Candida tropicalis, Candida glabrata, Candida rugosa, Candida krusei and Candida parapsilosis ranged between 25 and 100% at ..
  96. ncbi [Study on virulence factors of Candida tropicalis isolated from clinical samples]
    Shuanbao Yu
    State Key Laboratory for Communicable Diseases Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China
    Zhonghua Liu Xing Bing Xue Za Zhi 36:1162-6. 2015
    ..tropicalis, and analyze the differences in aspartyl proteinases and hemolytic activities of C. tropicalis isolated from anatomically distinct sites...
  97. doi Studies on the possible aetiological role of different Candida species in pathogenesis of dentine caries by monitoring the calcium release from tooth particles
    Bela Szabo
    University of Debrecen Department of Medical Microbiology Debrecen Hungary University of Debrecen Department of Medical Laboratory and Diagnostic Imaging, Medical and Health Science Centre Debrecen Hungary
    Acta Microbiol Immunol Hung 61:11-7. 2014
    ..surfaces were incubated in Sabouraud medium in the presence of six-six Candida albicans, Candida glabrata, Candida tropicalis, Candida krusei, Candida inconspicua and Candida norvegensis strains...
  98. pmc Diversity and fermentation products of xylose-utilizing yeasts isolated from buffalo feces in Thailand
    Wanlapa Lorliam
    Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University
    Microbes Environ 28:354-60. 2013
    ..analysis of the D1/D2 region of the large-subunit ribosomal RNA gene (LSU rDNA), they were identified as Candida tropicalis (designated as Group I, 11 isolates), Candida parasilosis (Group II, 2 isolates), Candida mengyuniae (Group ..
  99. pmc Proteogenomics of Candida tropicalis--An Opportunistic Pathogen with Importance for Global Health
    Keshava K Datta
    1 Institute of Bioinformatics, International Technology Park, Bangalore, India
    OMICS 20:239-47. 2016
    ..The situation is exacerbated by azole resistance developed by fungal pathogens. Candida tropicalis is an opportunistic pathogen that causes candidiasis, for example, in immune-compromised individuals, cancer ..
  100. doi Capsicum annuum L. trypsin inhibitor as a template scaffold for new drug development against pathogenic yeast
    Suzanna F F Ribeiro
    Centro de Biociencias e Biotecnologia, Universidade Estadual do Norte Fluminense, Campos dos Goytacazes, RJ, Brazil
    Antonie Van Leeuwenhoek 101:657-70. 2012
    ..The aim of this study was to determine the effect of CaTI on Saccharomyces cerevisiae, Candida albicans, Candida tropicalis and Kluyveromyces marxiannus cells. We observed that CaTI inhibited the growth of S. cerevisiae, K...
  101. ncbi Chemical composition and biological activities of essential oil from Hyptis crenata growing in the Brazilian cerrado
    Ivana Maria Póvoa Violante
    Centro de Cidncias Exatas e Tecnologia, Universidade Federal de Mato Grosso do Sul, Av Senador Filinto Muller 1555, Campo Grande, MS 79074 460, Brazil
    Nat Prod Commun 7:1387-9. 2012
    ..while the strongest fungicidal activities were against Cryptococcus neoformans, Candida glabrata and Candida tropicalis. The oil was also assessed for its anti-tick properties and, at a concentration of 2...

Research Grants14

  1. Allison M Porman; Fiscal Year: 2014
    ..Although Candida albicans is the most common fungal pathogen, infections due to Candida tropicalis have increased worldwide, establishing it as an emerging pathogen. Despite the importance of C...
  2. FIBRONECTIN RECEPTOR IN CANDIDA TROPICALIS
    MARGARET HOSTETTER; Fiscal Year: 2003
    Among Candida species, Candida tropicalis ranks second only to Candida albicans as a cause or morbidity and mortality among immunocompromised hosts, especially in patients undergoing cancer chemotherapy or those with fungal endocarditis...
  3. TARGETING PROTEINS TO CANDIDA TROPICALIS PEROXISOMES
    PAUL LAZAROW; Fiscal Year: 1990
    ..The exact nature of the topogenic sequences will be further investigated by site-directed mutagenesis...
  4. FUNCTION OF B-DEFENSINS IN COMMON ORAL INFECTIONS
    Janet Guthmiller; Fiscal Year: 2002
    ....
  5. Lethal synergism between influenza and pneumococcus
    Jonathan McCullers; Fiscal Year: 2003
    ....
  6. 2nd Orthomyxoviruses Research Conference
    Jonathan McCullers; Fiscal Year: 2003
    ..The purpose of this proposal is to provide funds that will allow promising young investigators to interact with their peers and develop a commitment to this area of research. ..
  7. Influenza-pneumococcal synergism: role of neuraminidase
    Jonathan McCullers; Fiscal Year: 2004
    ....
  8. High through-put detection of fungal pathogens
    JACK FELL; Fiscal Year: 2004
    ..Resulting data will be disseminated via GenBank, publications in leading scientific journals and as an inexpensive commercial detection system. ..
  9. Prevention/diagnosis/fungal infections/transplantation
    Barbara Alexander; Fiscal Year: 2005
    ..This approach will shorten the time from development to clinical implementation in therapeutic trials and guidelines. ..
  10. 3rd Orthomyxoviruses Research Conference
    Jonathan McCullers; Fiscal Year: 2005
    ..The purpose of this proposal is to provide funds that will allow promising young investigators to interact with their peers and develop a commitment to this area of research. ..
  11. Synergism Between Influenza Virus and Pneumococcus
    Jonathan McCullers; Fiscal Year: 2009
    ....
  12. NRG1 Regulation of Candida albicans Virulence
    Jose Lopez Ribot; Fiscal Year: 2004
    ..albicans virulence and ii) to identify downstream targets of Nrg1p under both planktonic and biofilm growing conditions. ..
  13. Small molecule inhibitors of Candida albicans biofilm formation
    Jose Lopez Ribot; Fiscal Year: 2008
    ..albicans to form biofilms, a substantial reduction in morbidity, mortality and extended hospital stay can be achieved while simultaneously reducing healthcare costs. [unreadable] [unreadable] [unreadable]..
  14. Host Immunity and Virulence in Candida albicans Pathogenesis
    Jose Lopez Ribot; Fiscal Year: 2009
    ..Results are likely to lead to the development of new immune-based strategies for the prevention and treatment of systemic candidiasis that are urgently needed. ..

Patents62

  1. BIOLOGICAL METHODS FOR PREPARING A FATTY DICARBOXYLIC ACID
    Patent Number: JP2016501040-A; Date:2016-01-18
  2. BIOLOGICAL METHODS FOR PREPARING A FATTY DICARBOXYLIC ACID
    Patent Number: JP2016501041-A; Date:2016-01-18
  3. NMR SYSTEMS AND METHODS FOR THE RAPID DETECTION OF ANALYTES
    Patent Number: EP2985633-A2; Date:2016-02-17
  4. NMR SYSTEMS AND METHODS FOR THE DETECTION OF ANALYTES
    Patent Number: JP2014505233-A; Date:2014-02-27
  5. Method for Simultaneous detection of pathogenic fungi
    Patent Number: WO2014133153-A; Date:2014-09-04
  6. Enzymatic omega-oxidation and omega-amination of fatty acid
    Patent Number: JP2015509730-A; Date:2015-04-02
  7. Method of identifying eukaryotic species
    Patent Number: JP2014155500-A; Date:2014-08-28
  8. Xylitol production method with high productivity using constitutive expression of xylose reductase
    Patent Number: KR1020110078548-A; Date:2011-07-07
  9. A hydrocarbon synthesis gene and use thereof
    Patent Number: WO2013129393-A; Date:2013-09-06
  10. PROCESS AND METHOD FOR MONITORING GASTROINTESTINAL MICROBIOTA
    Patent Number: EP2271771-A2; Date:2011-01-12
  11. VACCINE COMPOSITIONS AND METHODS FOR TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES
    Patent Number: EP2408804-A1; Date:2012-01-25
  12. Method of identifying and quantifying specific fungi and bacteria
    Patent Number: EP1484416-A2; Date:2004-12-08
  13. ENZYMATIC OMEGA-OXIDATION AND OMEGA-AMINATION OF FATTY ACIDS
    Patent Number: WO2013135650-A1; Date:2013-09-19
  14. Dna fragments, primers and method for amplification of the dna fragments and kit including the aforementioned primers for the detection and identification of clinically relevant candida species
    Patent Number: WO2006123295-A2; Date:2006-11-23
  15. Novel Candida tropicalis CJ-FID(KCTC 10457BP)and Manufacturing Method of Xylitol thereby
    Patent Number: JP2006528486-A; Date:2006-12-21
  16. Novel Candida tropicalis CJ-FID(KCTC 10457BP) and ManufacturingMethod of Xylitol thereby
    Patent Number: KR1020040033733-A; Date:2004-05-13
  17. Enhanced Multiplex FISH
    Patent Number: JP2013520980-A; Date:2013-06-10
  18. Xylitol producing-strain using the glucose as the co-substrate and high-producing fermentation methods using the same
    Patent Number: KR1020110097157-A; Date:2011-08-31
  19. Xylitol production method with high productivity using constitutive expression of xylose reductase
    Patent Number: KR1020110080138-A; Date:2011-07-12
  20. ENHANCED MULTIPLEX FISH
    Patent Number: KR1020130003002-A; Date:2013-01-08
  21. Process for the production of a fine chemical
    Patent Number: WO2008034648-A1; Date:2008-03-27
  22. Improvements in or relating to fatty acid metabolism
    Patent Number: WO9947685-A1; Date:1999-09-23
  23. Identifying organisms by detecting intronic nucleic acid or encoded proteins
    Patent Number: WO0114592-A2; Date:2001-03-01
  24. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
    Patent Number: WO0123604-A2; Date:2001-04-05
  25. Method of identifying eukaryotic species
    Patent Number: JP2010088398-A; Date:2010-04-22
  26. Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods thereto
    Patent Number: EP1148138-A2; Date:2001-10-24
  27. Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto
    Patent Number: EP1162268-A2; Date:2001-12-12
  28. NUCLEIC ACID SEQUENCES AND COMBINATION THEREOF FOR SENSITIVE AMPLIFICATION AND DETECTION OF BACTERIAL AND FUNGAL SEPSIS PATHOGENS
    Patent Number: JP2010532665-A; Date:2010-10-14
  29. Use of cyp52a2a promoter to increase gene expression in yeast
    Patent Number: WO0208412-A2; Date:2002-01-31
  30. Method of identifying and quantifying specific fungi and bacteria
    Patent Number: WO0196612-A2; Date:2001-12-20
  31. Cytochrome b5 gene and protein of candida tropicalis and methods relating thereto
    Patent Number: WO0208413-A2; Date:2002-01-31
  32. Process for the control of production of fine chemicals
    Patent Number: EP2199304-A1; Date:2010-06-23
  33. Nucleic acids probes for detection of yeast and fungal species
    Patent Number: WO2008072217-A2; Date:2008-06-19
  34. Plants with increased yield
    Patent Number: WO2009037279-A1; Date:2009-03-26
  35. Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
    Patent Number: WO03050276-A1; Date:2003-06-19
  36. Nucleic acid probes for detecting candida species
    Patent Number: JP2001512035-A; Date:2001-08-21
  37. Hygromycin resistance gene and transformed Candida yeast
    Patent Number: WO2000075307-A; Date:2000-12-14
  38. Nucleic acid for detecting fungus and method of detecting fungus by using the same
    Patent Number: JP2002142774-A; Date:2002-05-21
  39. Nucleic acid for detecting fungus belonging to the genus Candida and method of detecting fungus belonging to the genus Candida by using the same
    Patent Number: WO2002040713-A; Date:2002-05-23
  40. Nucleic acid for detecting fungus and method of detecting fungus using the same
    Patent Number: WO2002040663-A; Date:2002-05-23
  41. Process for the production of a fine chemical
    Patent Number: EP2090662-A2; Date:2009-08-19
  42. Process for the production of lutein
    Patent Number: EP2096177-A2; Date:2009-09-02
  43. Nucleic acid probes and methods for detecting clinically important fungal pathogens
    Patent Number: JP2003501049-A; Date:2003-01-14
  44. Ace2 as a target gene for the molecular identification of yeast and fungal species
    Patent Number: WO2009150243-A1; Date:2009-12-17
  45. P2/p2a/p2b gene sequences as diagnostic targets for the identification of fungal and yeast species
    Patent Number: WO2009150242-A1; Date:2009-12-17
  46. Process for the production of fine chemicals
    Patent Number: EP2194140-A2; Date:2010-06-09
  47. Pcr based diagnostic method for the identification of clinically important candida species
    Patent Number: WO2010061347-A1; Date:2010-06-03
  48. Nucleotide carrier for diagnosing and treating oral diseases
    Patent Number: WO02072883-A2; Date:2002-09-19
  49. New fungal elicitor protein and its use as resistance marker
    Patent Number: WO2010131960-A2; Date:2010-11-18
  50. New fungal elicitor protein and its use as resistance marker
    Patent Number: WO2010131946-A1; Date:2010-11-18
  51. HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE SPECIES-SPECIFIC, GENUS-SPECIFIC, FAMILY-SPECIFIC, GROUP-SPECIFIC AND UNIVERSAL NUCLEIC ACID PROBES AND AMPLIFICATION PRIMERS TO RAPIDLY DETECT AND IDENTIFY ALGAL, ARCHAEAL, BACTERIAL, FUNGAL AND PARASITICAL MICROOR-GANISMS FROM CLINICAL SPECIMENS FOR DIAGNOSIS
    Patent Number: JP2003511015-A; Date:2003-03-25
  52. SPECIES-SPECIFIC, GENIUS-SPECIFIC AND UNIVERSAL DNA PROBES AND AMPLIFICATION PRIMERS TO RAPIDLY DETECT AND IDENTIFY COMMON BACTERIAL AND FUNGAL PATHOGENS AND ASSOCIATED ANTIBIOTIC RESISTANCE GENES FROM CLINICAL SPECIMENS FOR DIAGNOSIS IN MICROBIOLOGY LABORATORIES
    Patent Number: JP2008289493-A; Date:2008-12-04
  53. Nucleic Acid Beacons for Fluorescent in-situ Hybridisation and Chip Technology
    Patent Number: JP2010505429-A; Date:2010-02-25
  54. Candida tropicalis cells and use thereof
    Patent Number: JP2011101643-A; Date:2011-05-26
  55. Process and Method for Monitoring Gastrointestinal Microbiota
    Patent Number: JP2011527177-A; Date:2011-10-27
  56. MANIPULATION OF SNF1 PROTEIN KINASE ACTIVITY FOR ALTERED OIL CONTENT IN OLEAGINOUS ORGANISMS
    Patent Number: JP2012501185-A; Date:2012-01-19
  57. Method for Detecting and Identifying Candida Species
    Patent Number: JP2012500019-A; Date:2012-01-05
  58. Nucleic acid probes and methods for detecting clinically important fungal pathogens
    Patent Number: JP2012120535-A; Date:2012-06-28
  59. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology labor
    Patent Number: JP2010094133-A; Date:2010-04-30
  60. VACCINE COMPOSITIONS AND METHODS FOR TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES
    Patent Number: JP2012520878-A; Date:2012-09-10
  61. ACE2AS A TARGET GENE FOR THE MOLECULAR IDENTIFICATION OF YEAST AND FUNGAL SPECIES
    Patent Number: JP2011522555-A; Date:2011-08-04
  62. EIF2 gene as a diagnostic target for the identification of fungal and yeast species
    Patent Number: JP2011524746-A; Date:2011-09-08